OncoC4 Appoints Dr. Steve Chen, JD, PhD as General Counsel
Yahoo Finance · Sep 1, 2026 · Vertex Pharmaceuticals Inc (VRTX)
OncoC4, Inc., a late clinical-stage biopharmaceutical company developing novel medicines for cancer and neurodegenerative diseases, today announced the appointment of Steve Chen, JD, PhD, as General Counsel.
Not investment advice. Cached headline, not a full reprint.